LumiraDx SARS-CoV-2 RNA STAR Complete is a rapid nucleic acid amplification method for the qualitative detection of SARS-CoV-2 in upper respiratory and saliva samples from individuals suspected of COVID-19. It utilizes a direct amplification method that combines lysis and amplification in a single step, without needing to perform any specimen purification and extraction in under 20 minutes. 

Benefits of SARS-CoV-2 RNA STAR Complete

  • Rapid - Reduces molecular laboratory workflow from approximately 3 hours to under 20 minutes
  • Accessible - Allows existing labs to use current infrastructure and achieve high throughput testing
  • Efficiency - Provides approximately a 6- to 8- fold increase of testing throughput over common open molecular systems
  • Supply - Eliminates need for sample preparation instrumentation and reagents

Test Workflow

LumiraDx SARS-CoV-2 RNA STAR Complete will enable laboratories to improve throughput by using current molecular infrastructure and eliminating the need for extraction and purification.

LumiraDx SARS-CoV-2 RNA STAR Complete reagents are for research use only and not for use in diagnostic procedures.

Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.